Aline Sherwood
Net worth: - $ as of 2026-05-30
Net worth: - $ as of 2026-05-30
Aline B. Sherwood worked as Senior Director-Strategic Communications at Cognition Therapeutics, Inc. from 2023 to 2025.
Served as Independent Director at Bio-Path Holdings, Inc. from 2022 to 2025.
Held the position of Head-Communications at The Liposome Co., Inc. Owned Scienta Communications LLC.
Completed undergraduate education at Beloit College.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-03-20 | 0 ( -.--% ) | - $ | 2026-05-30 |
| Companies | Position | End |
|---|---|---|
| COGNITION THERAPEUTICS, INC. | Corporate Officer/Principal | 2025-07-31 |
| BIO-PATH HOLDINGS, INC. | Director/Board Member | 2025-06-20 |
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Public Communications Contact | - |
Scienta Communications LLC | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
The Liposome Co., Inc.
The Liposome Co., Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures, and markets therapeutic products to treat cancer and related diseases | Health Technology |
Bio-Path Holdings, Inc.
Bio-Path Holdings, Inc. BiotechnologyHealth Technology Operates as a clinical stage biotechnology company, which focuses on developing therapeutic products | Health Technology |
Beloit College
Beloit College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cognition Therapeutics, Inc.
Cognition Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical stage neuroscience company that develops drugs to help restore normal cellular damage responses in neurodegenerative and neuro-ophthalmic disorders | Health Technology |
Scienta Communications LLC |
Select your edition
All financial news and data tailored to specific country editions